at the heart of value creation

Speedel
Hirschgässlein 11
4051 Basel

Auf Karte anzeigen
Öffnungszeiten
MO - FR: 08:00 - 17:00
Firmenbeschrieb
Speedel is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases.

Gründungsjahr
1998
 
Anzahl Mitarbeiter
75
 


Bilder
Marktleistungen
  • SPP100 (Aliskiren)
    Our lead product candidate SPP100 (Aliskiren), the first-in-class renin inhibitor, is partnered with Novartis for Phase III development and commercialisation in hypertension.
Eintrag erstellt: 13.09.2005, Letzte Änderung: 14.03.2007